ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1193

Seasonal Variation of Hospitalizations and In-Hospital Mortality Related to Systemic Lupus Erythematosus Among Adults in the United States: An Analysis of Nationwide Inpatient Sample

Jiayi Zheng1, Ruoning Ni2, Guangchen Zou3, Qianlan Xi4, Tien-Chan Hsieh3 and Shahrzad Abdollahi5, 1The Wright Center for Graduate Medical Education, Scranton, PA, 2Ascension Saint Agnes Hospital, Iowa City, IA, 3Danbury Hospital, Danbury, CT, 4Memorial Hospital West, Pembroke Pines, FL, 5Division of Rheumatology, Lewis Katz School of Medicine, Temple University Hospital, Philadelphia, PA

Meeting: ACR Convergence 2022

Keywords: Epidemiology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Epidemiology and Public Health Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: While the seasonal variation of systemic lupus erythematosus (SLE) disease activity has been reported, population-based studies are still lacking. Here we investigate the seasonal variations of hospitalizations and in-hospital mortality related to SLE using a US-based national database.

Methods: We examined adult SLE-related hospitalizations using Nationwide Inpatient Sample (NIS) from 2005 to 2019. Records of SLE-related hospitalizations were identified with ICD-9 code 710.0 and ICD-10 code M32. Weight-adjusted monthly hospitalizations and in-hospital death were used for analysis. In this study, we utilized two methods to examine the seasonality of SLE-related hospitalizations and in-hospital mortality. First, we conducted Poisson regression analysis to explore the trend of SLE-related hospitalization and in-hospital mortality over time (model 1 and model 2). Fourier series were later added to fit the seasonality component (model 3). Akaike’s Information Criterion (AIC) and analysis of variance (ANOVA) were used to compare the models and detect seasonality. Then, we performed Friedman test on detrended data to confirm the presence of seasonality. Finally, we analyzed the peak and trough of SLE-related hospitalization and in-hospital death among different age groups if seasonality was present using both methods. p < 0.05 was considered statistically significant. All statistical analyses were conducted using R Statistical Software, version 4.1.2 (R Foundation for Statistical Computing, Vienna, Austria).

Results: SLE-related hospitalizations increased, and SLE-related in-hospital mortality decreased over the study period. There was seasonal variation in the hospitalization and in-hospital death in adult SLE patients (Table 1). Among all adult patients, SLE-related hospitalizations were highest in January and lowest in February. SLE-related in-hospital mortality was highest in January and lowest in June. In patients aged between 18 and 40 years old, SLE-related hospitalizations were highest in January and lowest in February. In patients aged between 41 and 60 years old, SLE-related hospitalizations were highest in August and lowest in December. In patients aged 61 years or older, SLE-related hospitalizations were highest in January and lowest in February. SLE-related in-hospital mortality was highest in January and lowest in June (Figure 1).

Conclusion: There was an increase in the number of SLE-related hospitalizations and a decrease in SLE-related in-hospital mortality from 2005 to 2019. A significant seasonal component in SLE-related hospitalizations and in-hospital deaths was observed, although the patterns of seasonality varied among different age groups.

Supporting image 1

Figure 1: Seasonal Variation of SLE-related hospitalization and SLE-related in-hospital death using Nationwide Inpatient Sample (NIS) 2005 – 2019. SLE-related hospitalizations (A) and in-hospital death (B) in all adult patients. SLE-related hospitalizations (C) and in-hospital deaths (D) of adults aged between 18 years old and 40 years old. SLE-related hospitalizations (E) and in-hospital deaths (F) of adults aged between 41 years old and 60 years old. SLE-related hospitalizations (G) and in-hospital deaths (H) of patients aged 61 or older

Supporting image 2

Table 1: Seasonal Variation of Systemic Lupus Erythematosus-Related Hospitalizations and In-Hospital Mortality: Time-Series Regression Models and Friedman Test Results


Disclosures: J. Zheng, None; R. Ni, None; G. Zou, None; Q. Xi, None; T. Hsieh, None; S. Abdollahi, None.

To cite this abstract in AMA style:

Zheng J, Ni R, Zou G, Xi Q, Hsieh T, Abdollahi S. Seasonal Variation of Hospitalizations and In-Hospital Mortality Related to Systemic Lupus Erythematosus Among Adults in the United States: An Analysis of Nationwide Inpatient Sample [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/seasonal-variation-of-hospitalizations-and-in-hospital-mortality-related-to-systemic-lupus-erythematosus-among-adults-in-the-united-states-an-analysis-of-nationwide-inpatient-sample/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-variation-of-hospitalizations-and-in-hospital-mortality-related-to-systemic-lupus-erythematosus-among-adults-in-the-united-states-an-analysis-of-nationwide-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology